Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
Erkner E, Hentrich T, Schairer R, Fitzel R, Secker-Grob KA, Jeong J, Keppeler H, Korkmaz F, Schulze-Hentrich JM, Lengerke C, Schneidawind D, Schneidawind C. Erkner E, et al. Among authors: lengerke c. Oncogene. 2024 Jan;43(4):281-293. doi: 10.1038/s41388-023-02903-3. Epub 2023 Nov 29. Oncogene. 2024. PMID: 38030791 Free PMC article.
Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation.
Schneidawind D, Duerr-Stoerzer S, Liewer S, Renner S, Sánchez Navarro B, Atar D, Keppeler H, Beck R, Hamprecht K, Kanz L, Lengerke C, Schneidawind C. Schneidawind D, et al. Among authors: lengerke c. Transplant Cell Ther. 2022 Aug;28(8):513.e1-513.e4. doi: 10.1016/j.jtct.2022.05.011. Epub 2022 May 14. Transplant Cell Ther. 2022. PMID: 35580734 Free article.
Time-dependent analysis of adoptive immunotherapy following sequential FLAMSA-reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk myeloid neoplasia.
Weller JF, Mezger M, Seifert LL, Vogel W, Schneidawind D, Faul C, Bethge W, Lengerke C, Christopeit M. Weller JF, et al. Among authors: lengerke c. Eur J Haematol. 2022 Mar;108(3):244-263. doi: 10.1111/ejh.13732. Epub 2021 Dec 23. Eur J Haematol. 2022. PMID: 34902880
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
Konantz M, André MC, Ebinger M, Grauer M, Wang H, Grzywna S, Rothfuss OC, Lehle S, Kustikova OS, Salih HR, Handgretinger R, Fend F, Baum C, Kanz L, Quintanilla-Martinez L, Schulze-Osthoff K, Essmann F, Lengerke C. Konantz M, et al. Among authors: lengerke c. Leukemia. 2013 Jan;27(1):56-65. doi: 10.1038/leu.2012.211. Epub 2012 Jul 25. Leukemia. 2013. PMID: 22828445
151 results